Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Assets Average (2023 - 2026)

Longeveron (LGVN) posted quarterly Assets Average of $15.7 million for Q1 2026, down 32.18% year-over-year from $23.2 million in Q1 2025, and up 21.9% quarter-over-quarter from $12.9 million in Q4 2025.

Longeveron (LGVN) Assets Average (2023 - 2026) Analysis & Trends

Longeveron's Assets Average history runs 4 years deep, the most recent figure standing at $15.7 million for Q1 2026.

  • In Q1 2026, Assets Average fell 32.18% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (down 32.18% YoY), while the FY2025 annual figure was $17.9 million, down 4.83% from the prior year.
  • Assets Average for Q1 2026 stood at $15.7 million, up from $12.9 million in the prior quarter.
  • The five-year high for Assets Average was $27.7 million in Q4 2024, with the low at $10.9 million in Q1 2024.
  • The 4-year median for Assets Average is $16.2 million (2025), against an average of $18.1 million.
  • Peak annual rise in Assets Average reached 134.01% in 2024, while the deepest fall reached 55.76% in 2024.
  • Longeveron's Assets Average stood at $11.9 million in 2023, then surged by 134.01% to $27.7 million in 2024, then plunged by 53.45% to $12.9 million in 2025, then rose by 21.9% to $15.7 million in 2026.
  • Business Quant data shows LGVN's Assets Average at $15.7 million in Q1 2026, $12.9 million in Q4 2025, and $16.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.22 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 8.86 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.34 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.27 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.09 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 18.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.35 Mn
Mar 31, 2026 15.74 Mn
Dec 31, 2025 12.91 Mn
Sep 30, 2025 16.15 Mn
Jun 30, 2025 18.80 Mn
Mar 31, 2025 23.20 Mn
Dec 31, 2024 27.73 Mn
Sep 30, 2024 24.65 Mn
Jun 30, 2024 14.55 Mn
Mar 31, 2024 10.89 Mn
Dec 31, 2023 11.85 Mn
Sep 30, 2023 14.36 Mn
Jun 30, 2023 19.45 Mn
Mar 31, 2023 24.61 Mn